As we found in our case, IHC showed (Ki‐67 rate ~ 80%) and positivity of CD20, BCL2, and BCL6 with negativity for CD5 and CD3, confirming the diagnosis of recurrent DLBCL [11]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.